Schaeffer's Street Chatter Highlights the Following Stocks: InfoSpace, OSI Pharmaceuticals and palmOne.

CINCINNATI -- Today's "Street Chatter" from Schaeffer's Investment Research focuses on: InfoSpace (NASDAQ:INSP), OSI Pharmaceuticals (NASDAQ:OSIP) and palmOne (NASDAQ:PLMO). "Street Chatter" is a report that analyzes three newsworthy stocks that are generating a lot of attention on Internet message boards. "Street Chatter" is published on www.SchaeffersResearch.com - the home of Bernie Schaeffer and Schaeffer's Investment Research.

For additional information about this report or to have it delivered to you free via email every day click on the following link: http://www.schaeffersresearch.com/redirect.aspx?CODE=PRSC1M&PAGE=1

Street Chatter:

1. InfoSpace's (NASDAQ: INSP) website is a destination for Internet yellow pages and white pages information, providing directory-related services such as maps and directions and access to public records. Directory partners include WhitePages.com, MSN, AOL, and AT&T's Anywho.com. The firm also provides content for wireless and broadband applications, and owns search engine sites Dogpile, Webcrawler, and MetaCrawler. From its July low to its November high, the shares more than doubled in price, but this rise was put to a halt in November when a brokerage firm downgraded the shares from "strong buy" to "outperform." The analyst raised questions about the company on fears that one of its biggest customers may shift business away from INSP. Surprisingly, the same brokerage firm upgraded the shares back to a "strong buy" on November 18 on the belief that investor reaction to the original downgrade was overdone. Despite the upgrade, the security has yet to rebound. The stock has broken below its 10-day and 20-day moving average, pulling back to support near its 20-week trendline. INSP has not suffered a weekly close below this intermediate-term moving average since mid-August. Meanwhile, additional support in the form of the stock's 10-month trendline is moving into the area and has acted as a bastion of support since October 2002.

Pessimism is currently quite heavy on the shares. The stock's Schaeffer's put/call open interest ratio (SOIR) checks in at 0.82 and is higher than 71 percent of all those taken over the past 52 weeks. What's more, short interest continues to creep higher and is now resting at a two-year high. With almost 11 percent of the stock's float sold short, an unwinding of these positions could provide the shares with some short-covering support. On the other hand, Wall Street remains enamored of the firm, with six of the seven analysts following INSP rating it a "buy" or better. Investors should keep a close eye on support at the stock's 20-week moving average. A bounce higher off this support level could shake loose some of the bears, sending them running for cover.

Click the following link to see the Weekly Chart of INSP Since September 2002 With 10-Week and 20-Week Moving Averages: http://www.schaeffersresearch.com/wire?ID=11815

2. OSI Pharmaceuticals (NASDAQ: OSIP) gapped lower on November 19 despite the FDA announcing early approval of its cancer treatment Tarceva. Analysts are fearful that sales will not live up to expectations due to the stiff competition in this particular market. The stock's decline has continued this afternoon following a downgrade from "market perform" to "underperform." The shares have plunged lower over the past couple of days, breaking below support at their 10-week and 20-week moving averages. OSIP is also poised to close the month below its 10-month trendline for the first time since March 2003. Potential support still lies at the 50 level, which has served as both support and resistance in the past.

From a sentiment standpoint, investors and the Street are somewhat at odds with each other. The stock's SOIR of 0.69 is higher than roughly three-quarters of all those taken over the past 52 weeks. And while short interest is resting near an annual low, more than nine percent of the equity's float is still sold short. Wall Street remains optimistic, however, with seven of the 10 analysts following OSIP rating it a "buy" or better.

Click the following link to see the Monthly Chart of OSIP Since July 2000 with 10-Month Moving Average: http://www.schaeffersresearch.com/wire?ID=11815&obspage=2

3. palmOne (NASDAQ: PLMO) is a leading provider of handheld computers, offering products ranging from entry-level devices to pricier models that include features such as color displays. The company tops out with wireless devices that can access e-mail and Internet content, selling its products through distributors, wireless service carriers, retailers, and other resellers. PLMO announced this morning that it opened its first Treo store in San Jose, California. The new retail store will focus on the Treo smartphone family.

From a technical perspective, the shares have rallied more than 44 percent from their October 25 low using the support of their 10-day moving average. The security has also climbed back above its 10-week and 20-week trendlines. The stock has also rallied along the support of its of its 10-month moving average since March.

Options players have jumped on the security's bandwagon, as calls double puts in the front three months of options. Furthermore, PLMO's SOIR is lower than 96 percent of all those taken over the past 12 months. Meanwhile, short sellers remain convinced that the stock is due for a fall, as short interest surged 49 percent higher in October to 15.1 million -- a new multi-year high. What's more, this accumulation of bearish bets accounts for more than 35 percent of the stock's total float. Wall Street has decided to hang back, with just five analysts following PLMO. Of those five, three rate the stock a "buy" and two give it a "hold."

Looking ahead, Zacks reports that PLMO is slated to step into the earnings confessional on December 16. The Street is currently forecasting a profit of 53 cents per share, crushing its year-ago gain of seven cents per share. What's more, the company has thumped the consensus estimate for the past five quarters by an average of 240 percent. Another positive report could force some of the short sellers into unwinding their pessimistic positions, adding more fuel to the equity's rally.

Click the following link to see the Daily Chart of PLMO Since October 2004 with 10-Day Moving Average: http://www.schaeffersresearch.com/wire?ID=11815&obspage=2

The best way to take advantage of the timely Schaeffer commentaries is to sign up to receive their free e-newsletters -- Opening View, Midday Report, Market Recap and Monday Morning Outlook. Click here to have the Schaeffer's commentaries delivered to you free via email every day: http://www.schaeffersresearch.com/redirect.aspx?CODE=PRSC1M&PAGE=1

About Schaeffer's Investment Research (www.SchaeffersResearch.com)

Schaeffer's Investment Research, founded by Bernie Schaeffer in 1981, is a financial information and trading resources company. It publishes Bernie Schaeffer's Option Advisor, the nation's leading options subscription newsletter. The firm's contrarian approach focuses on stocks with technical and fundamental trends that run counter to investor expectations. The firm's website, http://www.SchaeffersResearch.com, is recognized as one of the leading information sources for stock and options traders and was cited as the top options website by both Forbes and Barron's. Click here for more details about Schaeffer's trading methodology: http://www.SchaeffersResearch.com/method.